| 1993 |
NHE2 (SLC9A2) encodes a functional Na+/H+ exchanger with 809 amino acids; stable expression in PS120 NHE-deficient fibroblasts confirmed amiloride-sensitive Na+-dependent intracellular alkalinization; NHE2 is 25-fold more resistant to ethylisopropylamiloride than NHE1; expression in Caco-2 cells results in apical membrane localization; serum activates NHE2. |
Stable transfection in PS120 fibroblasts, spectrofluorometric pH measurement, pharmacological profiling, expression in polarized Caco-2 cells |
The Journal of biological chemistry |
High |
7685025
|
| 1993 |
NHE2 cloned from rat intestinal cDNA library encodes a transporter with 10 transmembrane domains; transfection into PS120 NHE-deficient fibroblasts reconstitutes functional Na+/H+ exchange activity. |
cDNA cloning, transfection into NHE-deficient PS120 cells, functional Na+/H+ exchange assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
7683411
|
| 1993 |
Rat NHE2 stably expressed in NHE-deficient CHO (AP-1) cells shows Michaelis-Menten kinetics for extracellular Na+ (KNa ~50 mM), positive cooperative activation by intracellular H+ (pK ~6.90), and distinct pharmacological profile (EIPA K0.5=79 nM, amiloride K0.5=1.4 µM); Li+ and extracellular H+ act as competitive inhibitors of Na+ transport; K+ has no effect. |
Stable transfection in AP-1 CHO cells, 22Na+ influx assay, pharmacological and kinetic characterization |
The Journal of biological chemistry |
High |
8244989
|
| 1993 |
Kinetic analysis of NHE2 expressed in PS120 cells shows Vmax of 24.7 nmol/µl ICW/min and Km of 33.1 mM for Na+; KI for amiloride is 0.15 µM and for EIPA is 0.66 µM; EGF stimulates NHE2 activity; the first two transmembrane domains of NHEs are not essential for amiloride-sensitive Na+ transport. |
Stable transfection in PS120 cells, 22Na+ influx assay, kinetic analysis |
Biochimica et biophysica acta |
High |
8394136
|
| 1993 |
Leucine-143 in the fourth putative transmembrane domain of NHE2 is critical for amiloride and EIPA sensitivity; L143F substitution (mimicking NHE3) increases IC50 for amiloride 5-fold and EIPA 20-fold; these mutations do not alter Na+ affinity, indicating amiloride binding and Na+ transport sites are distinct. |
Site-directed mutagenesis of NHE2, stable expression in PS120 fibroblasts, pharmacological inhibition assays |
Biochemical and biophysical research communications |
High |
8512555
|
| 1995 |
NHE1, NHE2, and NHE3 are electroneutral and voltage-independent transporters; patch-clamp combined with microfluorimetry in CHO cells transfected with each isoform showed no transmembrane currents during Na+/H+ exchange and pHi changes were independent of holding voltage. |
Whole-cell patch clamp combined with microfluorimetric pH measurement in transfected CHO cells |
The Journal of general physiology |
High |
7494140
|
| 1996 |
NHE2 and NHE3 are localized to the brush-border (apical) but not basolateral membranes of villus epithelial cells in human and rabbit small intestine and colon, as determined by Western analysis of fractionated membranes and immunohistochemistry. |
Western blot of brush-border vs. basolateral membrane fractions, immunohistochemistry |
The American journal of physiology |
High |
8772498
|
| 1996 |
Hyperosmolarity (450 mosmol/kg) reversibly inhibits NHE2 and NHE3 by reducing maximal velocity without altering Km for intracellular H+ or extracellular Na+; this effect is opposite to the stimulatory effect of hyperosmolarity on NHE1; the COOH-terminus of NHE2 (truncation mutant E2/499) is not required for hyperosmolar inhibition. |
Spectrofluorometric pH measurement in PS120 fibroblasts stably transfected with NHE2 or NHE3 and COOH-terminal truncation mutants |
The American journal of physiology |
High |
8638709
|
| 1997 |
NHE2 protein (85 kDa) is localized to the apical membrane of cortical thick ascending limbs, distal convoluted tubules, and connecting tubules in rat kidney; absent in proximal tubule and collecting duct segments. |
Western blot of apical vs. basolateral membrane fractions, indirect immunolabeling on rat kidney sections |
The American journal of physiology |
High |
9729510
|
| 1997 |
NHE2 mRNA and protein are expressed in the apical membrane of medullary thick ascending limb (MTAL) in mouse and rat kidney, demonstrated by RT-PCR on microdissected tubules and immunofluorescence. |
RT-PCR of microdissected MTAL, immunofluorescence, Western blot of renal outer medulla membranes |
The Journal of membrane biology |
High |
9351894
|
| 1998 |
Under basal conditions, both NHE2 and NHE3 each contribute approximately 50% to ileal brush-border Na+/H+ exchange; glucocorticoids (methylprednisolone) selectively increase NHE3 activity (4.1-fold) and protein abundance without affecting NHE2 activity or protein levels. |
Radioisotopic 22Na+ flux in isolated rabbit ileal brush-border membranes, HOE-694 pharmacological separation of NHE2/NHE3 contributions, quantitative Western blot |
The American journal of physiology |
High |
9612213
|
| 1998 |
NHE2 expressed in inner medullary collecting duct (mIMCD-3) cells is localized to the basolateral membrane; high osmolality (510 mosmol/L) stimulates Na+/H+ exchange activity and increases NHE2 mRNA; acidic media (pH 7.1) decreases NHE2 mRNA. |
22Na+ uptake from apical vs. basolateral surface, Northern hybridization, osmolality manipulation |
The Journal of biological chemistry |
High |
7961730
|
| 1999 |
The COOH terminus of NHE2 contains separate stimulatory regulatory subdomains: PMA stimulation requires residues 573–660; okadaic acid stimulation requires residues 540–573; FGF stimulation requires residues 499–540; FBS stimulates even the most truncated mutant (E2/499). Calmodulin binds directly to the last 87 amino acids of NHE2 in a Ca2+-dependent manner (Kd=300 nM, stoichiometry 1:1) and inhibits basal NHE2 activity. |
COOH-terminal truncation mutants stably expressed in PS120 fibroblasts, second messenger stimulation assays, dansylated calmodulin fluorescence binding assay with GST-fusion protein |
The American journal of physiology |
High |
10199818
|
| 1999 |
A 45-residue region (residues 731–777) in the cytosolic domain of NHE2 is critical for apical targeting in renal epithelial cells; deletion of this region mistargeted NHE2 to the basolateral surface. This region binds the SH3 domain of α-spectrin in vitro. NHE2 is primarily at the plasma membrane (not recycling endosomes), unlike NHE3. |
Deletion mutagenesis, polar expression assays in renal epithelial cell line, in vitro SH3 binding assay |
Clinical and investigative medicine |
Medium |
10579058
|
| 1999 |
NHE2 expressed in intestinal C2/bbe cells localizes to the apical membrane and is inhibited by cAMP and Ca2+ (via changes in both KNa and Vmax) but is unaffected by phorbol ester/PKC; in contrast, NHE3 is inhibited by all three pathways, with cAMP and Ca2+ acting only on Vmax and PKC affecting both Vmax and KNa. |
Stable transfection in C2/bbe intestinal epithelial cells, unidirectional 22Na+ apical influx assay under non-acid-loaded conditions |
The Journal of membrane biology |
High |
10485997
|
| 1999 |
Human NHE2 (812 amino acids) expressed in NHE-deficient LAP1 cells catalyzes Na+-dependent pH recovery after acid load, inhibited by amiloride, confirming Na+/H+ exchange activity. |
Stable transfection in LAP1 NHE-deficient cells, pH recovery assay |
The American journal of physiology |
High |
10444453
|
| 2000 |
Macula densa cells express NHE2 at the apical membrane (sensitive to EIPA IC50=0.86 µM, Hoechst 694 IC50=7.6 µM) and NHE4 at the basolateral membrane (EIPA IC50=9.0 µM, insensitive to osmolality activation); NHE2 and NHE4 participate in Na+ transport, pHi, and cell volume regulation in macula densa. |
Isolated perfused thick ascending limb with attached glomerulus, intracellular pH fluorescence microscopy, pharmacological profiling with EIPA and Hoechst 694, immunohistochemistry |
American journal of physiology. Renal physiology |
High |
10710550
|
| 2001 |
Plasma membrane NHE2 has a short half-life of ~3 h compared to NHE1 (~24 h) and NHE3 (~14 h); NHE2 is degraded by lysosomes but not proteasomes; NHE2 activity is not affected by PI3-kinase inhibition and is not localized in the juxtanuclear recycling endosome, unlike NHE3. |
Cell surface biotinylation and pulse-chase in PS120 fibroblasts and Caco-2 cells, lysosome/proteasome inhibitors, PI3-kinase inhibitor treatment |
American journal of physiology. Cell physiology |
High |
11698263
|
| 2001 |
NHE2 and NHE3 are localized to the brush border of human duodenal villus cells; luminal amiloride at concentrations inhibiting NHE2 (10^-5–10^-4 M) or NHE3 (10^-3 M) caused step-wise increases in net duodenal HCO3- output in vivo, indicating that NHE2 and NHE3 participate in duodenal bicarbonate transport. |
Immunolocalization with polyclonal antibodies, in vivo luminal perfusion with graded amiloride doses in humans |
American journal of physiology. Gastrointestinal and liver physiology |
Medium |
11408268
|
| 2002 |
NHE3 is the dominant apical Na+/H+ exchanger for small intestinal Na+ absorption; NHE2 knockout mice show no reduction in net Na+ or Cl- absorption compared to wild-type; loss of NHE2 in NHE3-deficient mice causes no further impairment of acid-base status or worsening of diarrhea. |
NHE2 and NHE3 single and double knockout mice, radioisotopic Na+ and Cl- flux across isolated jejunum, systemic acid-base measurements |
American journal of physiology. Gastrointestinal and liver physiology |
High |
11705743 11960774
|
| 2003 |
The putative first extracellular loop (residues 41–53) of NHE2 exerts an inhibitory influence on hyperosmolarity-induced activation; point mutations or replacement of this region with the corresponding NHE1 sequence rendered NHE2 responsive to cell shrinkage-induced activation (regulatory volume increase), demonstrating the membrane domain controls differential volume sensitivity between NHE1 and NHE2. |
Chimeric exchangers and point mutations expressed in PS120 cells, confocal microscopy of cell volume, spectrofluorometric pHi measurement |
Biochemistry |
High |
12549930
|
| 2003 |
NHE2 is selectively expressed in the apical membrane of an immortalized TAL cell line (MKTAL); chronic (but not acute) nitric oxide donor exposure inhibits NHE2 activity and downregulates NHE2 mRNA. |
Immortalized TAL cell line, apical vs. basolateral pHi recovery assays, Western blot, mRNA analysis, NO donor treatment |
Pflugers Archiv : European journal of physiology |
Medium |
12836026
|
| 2007 |
NHE2-CFP translocates to the plasma membrane in response to intracellular acidification, whereas NHE3-CFP translocates in response to extracellular Na+ removal; chimeric NHE2/NHE3 proteins showed the Na+-removal response resides in the NHE3 cytoplasmic tail, and the acidification response sequence is distinct and located in NHE2. |
NHE2-CFP and NHE3-CFP fusion proteins transiently expressed in PS120 cells, confocal morphometry with FM4-64 plasma membrane labeling, chimeric protein analysis |
Biochimica et biophysica acta |
High |
17303069
|
| 2008 |
NHE2 activity mediates functional coupling with the DRA Cl-/base exchanger; transfection of NHE2 into Caco2BBE cells increased apical 36Cl- uptake; coupled NHE2/DRA activity was inhibited by elevated cAMP and calcium and was associated with synaptotagmin I-dependent, clathrin-mediated endocytosis. |
22Na+ and 36Cl- uptake assays in Caco2BBE cells, tet-off inducible DRA transgene, pharmacological inhibition, endocytosis pathway analysis |
American journal of physiology. Gastrointestinal and liver physiology |
High |
19056765
|
| 2008 |
NHE2 at the macula densa apical membrane plays a role in tubuloglomerular feedback control of renin secretion; NHE2 knockout mice show ~2.5-fold increase in renin-expressing cells, elevated renal renin content and activity, and chronic activation of ERK1/2 in macula densa cells, with upregulation of COX-2 and mPGES, indicating MD cell shrinkage-ERK1/2-COX2-PGE2-renin signaling pathway. |
NHE2 knockout mice, renin immunohistochemistry, Western blot, ERK1/2 phosphorylation assay, COX-2/mPGES expression, NHE inhibitor treatment of MMDD1 cells |
American journal of physiology. Renal physiology |
High |
18287398
|
| 2009 |
NHE2 alpha2-adrenergic receptor stimulation (via clonidine) promotes exocytosis of NHE2 to the apical surface and inhibits cAMP- and Ca2+-induced NHE2 endocytosis; the signaling pathway involves phospholipase C, arachidonic acid epoxygenase, EGF receptor transactivation, and PI3-kinase/Akt. |
Caco2-3B cells expressing human alpha2A-adrenergic receptor, 22Na+ uptake, apical surface NHE abundance by Western blot, pharmacological pathway dissection |
The Journal of pharmacology and experimental therapeutics |
Medium |
19556451
|
| 2011 |
PMA activates NHE2 transcription via a PKCδ → MEK-ERK1/2 → Egr-1 signaling axis; PKCδ knockdown by siRNA or rottlerin blocked PMA-induced NHE2 promoter activity; ERK1/2 inhibition by U0126 abrogated Egr-1 expression and its nuclear translocation and interaction with the NHE2 promoter. |
siRNA knockdown, pharmacological inhibitors, reporter gene assay, immunofluorescence, chromatin immunoprecipitation in C2BBe1 cells |
American journal of physiology. Gastrointestinal and liver physiology |
High |
22052014
|
| 2011 |
Uroguanylin reduces NHE2 activity at the apical membrane via a GC-C/cGMP-mediated pathway (enhanced by PDE5 inhibitor sildenafil), resulting in reduced Na+ absorption and increased net secretory fluid flow in T84 cells. |
Transepithelial fluid flow measurement by optic techniques, intracellular pH fluorescence, pharmacological inhibitors in T84 cells |
Cellular physiology and biochemistry |
Medium |
22178885
|
| 2013 |
Extracellular acidosis induces NHE2 transcriptional upregulation through Egr-1; acid treatment increases Egr-1 mRNA and protein, promotes its nuclear accumulation, and potentiates Egr-1 binding to a GC-rich element (bp -337 to -323) in the NHE2 promoter; siRNA knockdown of Egr-1 abrogates acid-induced NHE2 transcriptional activity. |
RT-PCR, Western blot, reporter gene assay with deletion/mutation analysis, immunofluorescence, in vitro and in vivo protein-DNA interaction assays, Egr-1 siRNA in C2BBe1 and SK-CO15 cells |
PloS one |
High |
24376510
|
| 2015 |
In DSS-induced colonic inflammation, NHE2 (not NHE3) mediates butyrate-dependent Na+ absorption; in normal colon NHE3 mediates both HCO3--dependent and butyrate-dependent Na+ absorption; inflammation activates NHE2 which mediates butyrate-dependent Na+ absorption, inhibited by HOE694 but not S3226. |
In vitro voltage-clamp Na+ flux in isolated rat colon, pharmacological inhibitors (HOE694 for NHE2, S3226 for NHE3), Western blot, DSS colitis model |
The Journal of biological chemistry |
High |
26350456
|
| 2017 |
NHE2 expressed in gastric surface cells (RGM1) via lentiviral gene transfer increases steady-state pHi and reduces epithelial restitution velocity after low pH preincubation; pharmacological NHE2 inhibition reverses this effect, indicating NHE2 activity inhibits cell migration while NHE1 promotes it. |
Lentiviral NHE2 overexpression in RGM1 cells, DiR-based wound healing assay, pharmacological NHE inhibition, pH measurements |
Journal of cellular physiology |
Medium |
28019659
|
| 2001 |
NHE2 transcription in renal mIMCD-3 cells is driven by two Sp1 binding sites in a minimal promoter (-36 to +116); Sp1 activates transcription >100-fold in Drosophila SL2 cells lacking endogenous Sp1, while Sp3 and Sp4 do not activate but repress Sp1-mediated transcription by competing for binding. |
Luciferase reporter assays, electrophoretic mobility shift assay (EMSA), mutagenesis, co-transfection in Drosophila SL2 cells, antisera supershift in mIMCD-3 cells |
American journal of physiology. Cell physiology |
High |
11287330
|
| 2010 |
TNF-α represses NHE2 expression and activity via NF-κB activation; NF-κB subunits p50 and p65 bind a κB motif within bp -621 to -471 of the NHE2 promoter; mutation of this motif abolishes NF-κB-DNA interaction and abrogates TNF-α-induced repression; two NF-κB inhibitors block the inhibitory effect of TNF-α. |
Reporter gene assays, EMSA, ChIP, ectopic NF-κB overexpression, NF-κB inhibitors, 22Na uptake in C2BBe1 cells |
Inflammatory bowel diseases |
High |
20722069
|
| 2024 |
zDHHC3-mediated S-palmitoylation of SLC9A2 regulates apoptosis in kidney clear cell carcinoma; zDHHC3 suppression decreases SLC9A2 expression and S-palmitoylation, which inhibits Caki-2 cell apoptosis. |
Bioinformatics, pan-cancer analysis, cell experiments with zDHHC3 suppression, detection of S-palmitoylation and SLC9A2 expression |
Journal of cancer research and clinical oncology |
Low |
38619631
|
| 2017 |
NHE2 mediates a regulatory volume increase (RVI) mechanism that promotes cell cycle progression (S and G2/M phases) in AQP2-expressing renal collecting duct cells; NHE2 protein activity and expression are increased in AQP2-expressing cells, and NHE2 inhibition specifically reduces proliferation and delays cell cycle only when AQP2 is expressed. |
AQP2-transfected RCCD1 and mpkCCDc14 cell lines, NHE2 activity assay, cell cycle analysis, pharmacological NHE2 inhibition |
Journal of cellular biochemistry |
Medium |
27191152
|